Dan Ru
Impact in
-
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 2
- Extracellular vesicles in disease 2
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Yourong Duan (4 shared papers)Ming Shen (4 shared papers)Qianqian Guo (1 shared paper)Ke Gong (1 shared paper)Di He (1 shared paper)Li He (1 shared paper)Fangfang Liu (1 shared paper)Liting Wang (1 shared paper)
In The Last Decade
Dan Ru
7 papers receiving 356 citations
Dan Ru's Hit Papers
Peers
Comparison fields: 5 of 60
- Cancer Research 125
- Biomaterials 86
- Complementary and alternative medicine 36
- Molecular Biology 273
- Biomedical Engineering 94
Countries citing papers authored by Dan Ru
This map shows the geographic impact of Dan Ru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Ru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Ru more than expected).
Fields of papers citing papers by Dan Ru
This network shows the impact of papers produced by Dan Ru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Ru. The network helps show where Dan Ru may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Ru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer Hit paper breakdown → | 2022 | 157 |
| 2 | 2019 | 98 | |
| 3 | 2019 | 63 | |
| 4 | 2018 | 25 | |
| 5 | 2017 | 14 | |
| 6 | 2025 | 1 | |
| 7 | 2025 | 1 | |
| 8 | 2025 | 0 |
About Dan Ru
Dan Ru is a scholar working on Molecular Biology, Biomaterials, Complementary and alternative medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 359 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Natural Compounds in Disease Treatment (4 papers), Ferroptosis and cancer prognosis (2 papers), MicroRNA in disease regulation (2 papers), RNA Interference and Gene Delivery (2 papers), Extracellular vesicles in disease (2 papers), Nanoplatforms for cancer theranostics (1 paper) and Flavonoids in Medical Research (1 paper). The work is most often cited by research in Cancer Research (125 citations), Biomaterials (86 citations), Complementary and alternative medicine (36 citations), Molecular Biology (273 citations) and Biomedical Engineering (94 citations). Dan Ru has collaborated with scholars based in China and Australia. Frequent co-authors include Yourong Duan, Ming Shen, Qianqian Guo, Ke Gong, Di He, Li He, Fangfang Liu, Liting Wang, Dewei Zhao and He Li. Their work appears in journals such as Journal of Biomedical Nanotechnology, Theranostics, Scientific Reports, The American Journal of Chinese Medicine and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.